• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

2.200 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 540
Open 2.200
Bid (Size) 2.110 (14)
Ask (Size) 2.210 (2)
Prev. Close 2.200
Today's Range 2.200 - 2.200
52wk Range 1.620 - 14.67
Shares Outstanding 2,370,698
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks that are showing activity before the opening bell on Wednesday.
July 23, 2025
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 23, 2025
 
Via Benzinga

Performance

YTD
-73.3%
-73.3%
1 Month
-1.3%
-1.3%
3 Month
-27.9%
-27.9%
6 Month
-69.2%
-69.2%
1 Year
-67.4%
-67.4%

More News

Read More
Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse
July 16, 2025
Via ACCESS Newswire
Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2
June 24, 2025
Via ACCESS Newswire
Ensysce Biosciences Awarded $5.3 Million in Continued NIDA Support to Advance Breakthrough Opioid Overdose Protection
June 04, 2025
Via ACCESS Newswire
Ensysce Biosciences Announces Speakers for Major Symposium at PAINWeek 2025
June 11, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
May 16, 2025
Via Benzinga
Ensysce Biosciences Reports First Quarter 2025 Financial Results
May 13, 2025
Via ACCESS Newswire
Ensysce Biosciences Bolsters Management Team with Regulatory Expert
May 12, 2025
Via ACCESS Newswire
Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
April 24, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Intraday Session
April 24, 2025
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 24, 2025
Via Benzinga
Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
April 24, 2025
Via Benzinga
Top movers in Wednesday's after hours session
April 23, 2025
Via Chartmill
Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why
April 23, 2025
Via Benzinga
Topics Intellectual Property
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 23, 2025
Via Benzinga
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 23, 2025
Via Benzinga
Crude Oil Falls Over 3%; Philip Morris Earnings Top Views
April 23, 2025
Via Benzinga
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results
April 23, 2025
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 23, 2025
Via Benzinga
Ensysce Biosciences Receives U.S. Patent for Groundbreaking Treatment of Opioid Use Disorder
April 23, 2025
Via ACCESS Newswire
Ensysce Biosciences Stock Rises On Positive Data From Opioid Overdose Protection Study: Retail’s Thrilled
April 15, 2025
Via Stocktwits
Topics Government
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 15, 2025
Via Benzinga
Ensysce Biosciences Announces Positive Data from Opioid Overdose Protection Study
April 15, 2025
Via ACCESS Newswire

Frequently Asked Questions

Is Ensysce Biosciences, Inc. - Common Stock publicly traded?
Yes, Ensysce Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Ensysce Biosciences, Inc. - Common Stock trade on?
Ensysce Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ensysce Biosciences, Inc. - Common Stock?
The ticker symbol for Ensysce Biosciences, Inc. - Common Stock is ENSC on the Nasdaq Stock Market
What is the current price of Ensysce Biosciences, Inc. - Common Stock?
The current price of Ensysce Biosciences, Inc. - Common Stock is 2.200
When was Ensysce Biosciences, Inc. - Common Stock last traded?
The last trade of Ensysce Biosciences, Inc. - Common Stock was at 07/29/25 04:00 PM ET
What is the market capitalization of Ensysce Biosciences, Inc. - Common Stock?
The market capitalization of Ensysce Biosciences, Inc. - Common Stock is 5.22M
How many shares of Ensysce Biosciences, Inc. - Common Stock are outstanding?
Ensysce Biosciences, Inc. - Common Stock has 5M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap